Reference
Terlipressin: new recommendations to reduce risks of respiratory failure and septic shock in patients with type 1 hepatorenal syndrome Drug Safety Update 16: No. 8, Mar 2023. Available from: URL: https://www.gov.uk/drug-safety-update/terlipressin-new-recommendations-to-reduce-risks-of-respiratory-failure-and-septic-shock-in-patients-with-type-1-hepatorenal-syndrome
Rights and permissions
About this article
Cite this article
Measures for reducing risks of respiratory failure and sepsis with terlipressin. Reactions Weekly 1950, 6 (2023). https://doi.org/10.1007/s40278-023-36403-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-36403-0